GlassScriptPhysician profile
Amy Lynn Basile
NPI 1487897617
$5,540.04
in general payments reported to CMS, 2019-2025
31 companies · $1,683 in 2025
The $1,683 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $597 · 2021: $554 · 2022: $505 · 2023: $649 · 2024: $872 · 2025: $1,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,203.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,457.83 | 2019-2025 | Tremfya |
| Abbvie INC. | $1,238.44 | 2019-2025 | Rinvoq, Skyrizi |
| Regeneron Healthcare Solutions, INC. | $414.81 | 2019-2025 | Dupixent, Libtayo |
| Amgen INC. | $270.98 | 2019-2025 | Otezla, Otezla |
| Leo Pharma INC. | $238.01 | 2020-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $224.65 | 2019-2025 | |
| Galderma Laboratories, L.P. | $224.33 | 2019-2025 | Aklief, Nemluvio |
| Pfizer INC. | $182.52 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $175.73 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $165.36 | 2019-2025 | |
| Lilly USA, LLC | $130.12 | 2019-2024 | Taltz, Ebglyss, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $114.19 | 2023-2025 | Sotyktu |
| Ucb, INC. | $108.76 | 2019-2025 | Bimzelx |
| Dermavant Sciences, INC. | $80.82 | 2023-2024 | Vtama |
| Incyte Corporation | $76.20 | 2021-2023 | Opzelura |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $48.60 | 2019 | |
| Strata Skin Sciences, INC. | $44.37 | 2024-2025 | Xtrac |
| Dusa Pharmaceuticals, INC. | $38.37 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.64 | 2021-2025 | Cabtreo |
| Verrica Pharmaceuticals INC. | $36.57 | 2023-2025 | Ycanth |
| Genentech USA, INC. | $31.70 | 2019 | |
| Biofrontera INC. | $28.26 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $27.71 | 2023-2025 | Valchlor |
| Sientra, INC. | $24.95 | 2019 | |
| Arcutis Biotherapeutics, INC. | $19.83 | 2023 | |
| Botanix Sb INC | $18.10 | 2025 | Sofdra |
| Misonix INC | $17.22 | 2020 | |
| Kyowa Kirin, INC. | $17.19 | 2023 | Poteligeo |
| Lnhc, INC | $17.00 | 2025 | Zelsuvmi |
| Organon LLC | $16.56 | 2025 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.22 | 2024 | Spevigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Basile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.